Interestingly, ATO inhibits the interaction of the corepressor SMRT with the fusion protein promyelocytic leukemia-retinoic acid receptor-a (PML-RARa) contributing to possible mechanisms in iAs-mediated remission in acute promyelocytic leukemia (APL) [65], [66]. Here, RARA is linked to acute promyelocytic leukemia.